Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000386990

Medchemexpress LLC Quinazoline, 6,7-dimethoxy-4-[(3R)-3-(2-quinoxalinyloxy)-1-pyrrolidinyl]- | 927691-21-2 | 99.8% | 403.43 | 50 MG
SDP

Catalog No. 5000386990
Encompass_Preferred

PQ-10 is a potent inhibitor of Phosphodiesterase 10A (PDE10A) with IC50 and ED50 values of 4.6 nM and 13 mg/kg, respectively. It induces patterns of brain glucose metabolism, which can serve as a potential translational biomarker. It has the potential for researching psychiatric disorders like schizophrenia.

  • Potent inhibitor of Phosphodiesterase 10A (PDE10A)
  • IC50 of 4.6 nM
  • ED50 of 13 mg/kg
  • Induces patterns of brain glucose metabolism
  • Potential translational biomarker
  • Potential for researching psychiatric disorders like schizophrenia

Catalog No. 50-003-86990 Supplier Medchemexpress LLC Supplier No. HY1807850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PQ-10 is a potent inhibitor of Phosphodiesterase 10A (PDE10A) with IC50 and ED50 values of 4.6 nM and 13 mg/kg, respectively. It induces patterns of brain glucose metabolism, which can serve as a potential translational biomarker. It has the potential for researching psychiatric disorders like schizophrenia.

  • Potent inhibitor of Phosphodiesterase 10A (PDE10A)
  • IC50 of 4.6 nM
  • ED50 of 13 mg/kg
  • Induces patterns of brain glucose metabolism
  • Potential translational biomarker
  • Potential for researching psychiatric disorders like schizophrenia

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.